| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 33931 |
Xpeptide-PEG-PCL Xpeptide多肽-聚乙二醇-聚已内酯 |
64 |
kx |
2025-02-10 |
| 33932 |
DSPE-PEG2000-Biotin,740794-01-8,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-生物素,DSPE-PEG-Biotin |
60 |
axc |
2025-02-10 |
| 33933 |
DSPE-PEG5-azide,2112737-73-0,二硬脂酰基磷脂酰乙醇胺-五聚乙二醇-叠氮,DSPE-PEG-azide |
55 |
axc |
2025-02-10 |
| 33934 |
FITC/CY3/CY5/CY7荧光标记方法步骤 |
64 |
WYQ |
2025-02-10 |
| 33935 |
M2pep-PEG-PCL M2型巨噬细胞靶向肽-聚乙二醇-聚已内酯 |
48 |
kx |
2025-02-10 |
| 33936 |
Br-PEG1000-Br 溴-聚乙二醇-溴 |
64 |
zyl |
2025-02-10 |
| 33937 |
选择合适的荧光染料和特异性荧光显微镜 |
74 |
WYQ |
2025-02-10 |
| 33938 |
DSPE-PEG2000-azide,1938081-39-0,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-叠氮,DSPE-PEG-azide |
62 |
axc |
2025-02-10 |
| 33939 |
荧光FITC标记多糖的方法步骤 |
95 |
WYQ |
2025-02-10 |
| 33940 |
DSPE-PEG2000-Amine,474922-26-4,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-氨基,DSPE-PEG-Amine |
59 |
axc |
2025-02-10 |
| 33941 |
T7-PEG-PCL 脑靶向肽T7-聚乙二醇-聚已内酯 |
77 |
kx |
2025-02-10 |
| 33942 |
DSPE-PEG2000-Ald,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-醛基,DSPE-PEG-Ald |
99 |
axc |
2025-02-10 |
| 33943 |
COCl-PEG1000-COCl 琥珀酰氯-聚乙二醇-琥珀酰氯 |
90 |
zyl |
2025-02-10 |
| 33944 |
DSPE-PEG2000-acid,2112738-58-4,二硬脂酰基磷脂酰乙醇胺-四聚乙二醇-羧酸,DSPE-PEG4-acid |
52 |
axc |
2025-02-10 |
| 33945 |
提取和纯化灰树花多糖的方法 |
70 |
WYQ |
2025-02-10 |
| 33946 |
DSPE-PEG2000-acid,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-羧酸,DSPE-PEG-acid |
46 |
axc |
2025-02-10 |
| 33947 |
Cl-PEG1000-Cl 氯化物-聚乙二醇-氯化物 |
81 |
zyl |
2025-02-10 |
| 33948 |
Peptides PEG PCL 多肽-聚乙二醇-聚已内酯 |
74 |
kx |
2025-02-10 |
| 33949 |
Peptides-PEG-PCL 多肽-聚乙二醇-聚已内酯 |
56 |
kx |
2025-02-10 |
| 33950 |
IA-PEG1000-SC 碘代乙酰基-聚乙二醇-琥珀酰亚胺碳酸酯 |
59 |
zyl |
2025-02-10 |
| 33951 |
IA-PEG1000-Mal 碘代乙酰基-聚乙二醇-马来酰亚胺 |
62 |
zyl |
2025-02-10 |
| 33952 |
FITC标记PGF灰树花多糖时调节温度的原因 |
56 |
WYQ |
2025-02-10 |
| 33953 |
Peptides PEG PLA 多肽-聚乙二醇-聚乳酸 |
54 |
kx |
2025-02-10 |
| 33954 |
IA-PEG1000-Biotin 碘代乙酰基-聚乙二醇-生物素 |
62 |
zyl |
2025-02-10 |
| 33955 |
PTP-PEG-N3 胰腺癌靶向肽PTP-聚乙二醇-叠氮 |
63 |
kx |
2025-02-10 |
| 33956 |
PTP-PEG-COOH 胰腺癌靶向肽PTP-聚乙二醇-羧酸 |
49 |
kx |
2025-02-10 |
| 33957 |
PTP PEG 胰腺癌靶向肽PTP-聚乙二醇 |
54 |
kx |
2025-02-10 |
| 33958 |
FITC标记PGF灰树花多糖时调节pH值的原因 |
54 |
WYQ |
2025-02-10 |
| 33959 |
Angiopep-2-PEG-N3 脑部靶向分子-聚乙二醇-叠氮 |
50 |
kx |
2025-02-10 |
| 33960 |
Angiopep-2-PEG-COOH 脑部靶向分子-聚乙二醇-羧酸 |
49 |
kx |
2025-02-10 |
| 33961 |
Angiopep-2 PEG 脑部靶向分子-聚乙二醇 |
114 |
kx |
2025-02-10 |
| 33962 |
iRGD-PEG-MAL 环肽iRGD-聚乙二醇-马来酰亚胺 |
55 |
kx |
2025-02-10 |
| 33963 |
iRGD-PEG-N3 环肽iRGD-聚乙二醇-叠氮 |
61 |
kx |
2025-02-10 |
| 33964 |
iRGD-PEG-SH 环肽iRGD-聚乙二醇-硫基 |
52 |
kx |
2025-02-10 |
| 33965 |
FITC-PGF荧光标记反应结束后纯化标记的灰树花多糖 |
72 |
WYQ |
2025-02-10 |
| 33966 |
cRGD-PEG-PEI cRGD靶向环肽-聚乙二醇-聚乙烯亚胺 |
68 |
kx |
2025-02-10 |
| 33967 |
1622335-40-3，ICG-NHS吲哚菁绿-活性酯 |
57 |
WYQ |
2025-02-10 |
| 33968 |
IA-PEG1000-COOH 碘代乙酰基-聚乙二醇-羧基 |
88 |
zyl |
2025-02-10 |
| 33969 |
ICG-NHS吲哚菁绿活化酯试剂的保存与检测 |
69 |
WYQ |
2025-02-10 |
| 33970 |
Br-PEG1000-Mal 溴-聚乙二醇-马来酰亚胺 |
49 |
zyl |
2025-02-10 |
| 33971 |
cRGD-PEG-N3 cRGD靶向环肽-聚乙二醇-叠氮 |
47 |
kx |
2025-02-10 |
| 33972 |
ICG-NHS标记后的生物分子光谱分析验证方法 |
77 |
WYQ |
2025-02-10 |
| 33973 |
Alkyne-PEG1000-IA 炔烃-聚乙二醇-碘代乙酰基 |
46 |
zyl |
2025-02-10 |
| 33974 |
CY7-Calcipotriol，荧光染料CY7标记卡泊三醇的性质 |
81 |
WYQ |
2025-02-10 |
| 33975 |
cRGD-PEG-SH cRGD靶向环肽-聚乙二醇-巯基 |
70 |
kx |
2025-02-10 |
齐岳微信公众号
官方微信
库存查询